Table 3.

Adverse Event rates among all 36 treated patients

Adverse Event	N (%)	90% confidence limits		Grade
		Lower	Upper
Headache	2 (6%)	2%	15%	3
Gastrointestinal toxicity	0 (0%)	0%	7%	N/A
Hematologic toxicity	0 (0%)	0%	7%	N/A
Hyperglycemia	0 (0%)	0%	7%	N/A
Hyponatremia	0 (0%)	0%	7%	N/A
Increased creatinine	0 (0%)	0%	7%	N/A
Increase in coagulation parameters	0 (0%)	0%	7%	N/A

N/A = Not applicable.